Free Trial

Nutex Health (NASDAQ:NUTX) Trading Down 5% - Should You Sell?

Nutex Health logo with Medical background

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price was down 5% on Wednesday . The stock traded as low as $17.66 and last traded at $18.57. 88,118 shares traded hands during mid-day trading, an increase of 122% from the average daily volume of 39,663 shares. The stock had previously closed at $19.54.

Analyst Ratings Changes

Several analysts recently commented on the stock. Maxim Group started coverage on shares of Nutex Health in a report on Wednesday, September 18th. They set a "buy" rating and a $45.00 price target for the company. Benchmark boosted their target price on shares of Nutex Health from $30.00 to $45.00 and gave the stock a "buy" rating in a research report on Wednesday, August 21st.

Read Our Latest Stock Analysis on NUTX

Nutex Health Price Performance

The firm has a market capitalization of $94.07 million, a P/E ratio of -1.79 and a beta of 0.10. The company has a debt-to-equity ratio of 3.04, a current ratio of 1.59 and a quick ratio of 1.55. The company's 50 day moving average price is $19.15 and its 200 day moving average price is $11.48.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.29) by $0.22. Nutex Health had a negative return on equity of 43.79% and a negative net margin of 13.73%. The firm had revenue of $76.08 million during the quarter.

Insider Activity

In other news, CFO Jon Christian Bates bought 1,350 shares of the company's stock in a transaction dated Thursday, August 22nd. The stock was bought at an average cost of $21.46 per share, for a total transaction of $28,971.00. Following the transaction, the chief financial officer now owns 2,277 shares of the company's stock, valued at $48,864.42. This represents a 100.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 38.52% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Essex Investment Management Co. LLC bought a new stake in Nutex Health during the 3rd quarter worth approximately $1,579,000. Beaird Harris Wealth Management LLC grew its position in Nutex Health by 210.0% during the fourth quarter. Beaird Harris Wealth Management LLC now owns 930,282 shares of the company's stock worth $167,000 after buying an additional 630,168 shares in the last quarter. Finally, One Plus One Wealth Management LLC increased its position in shares of Nutex Health by 2,017.5% in the first quarter. One Plus One Wealth Management LLC now owns 5,293,720 shares of the company's stock worth $508,000 after purchasing an additional 5,043,720 shares during the last quarter. Institutional investors own 5.32% of the company's stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Further Reading

→ Next opportunity for crypto millions (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Nutex Health right now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines